Ventyx Biosciences, Inc.VTYXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | -20.48% |
| Q2 2025 | -2.76% |
| Q1 2025 | -7.75% |
| Q4 2024 | -18.96% |
| Q3 2024 | 10.16% |
| Q2 2024 | -17.61% |
| Q1 2024 | -19.69% |
| Q4 2023 | -15.54% |
| Q3 2023 | 2.45% |
| Q2 2023 | 37.03% |
| Q1 2023 | 17.40% |
| Q4 2022 | 18.52% |
| Q3 2022 | 73.54% |
| Q2 2022 | -15.70% |
| Q1 2022 | 25.93% |
| Q4 2021 | 31.10% |
| Q3 2021 | 10.87% |
| Q2 2021 | -61.34% |
| Q1 2021 | 1782.25% |
| Q4 2020 | -34.32% |
| Q3 2020 | 29.68% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |